Acute warfarin toxicity: An unanticipated consequence of amoxicillin/clavulanate administration

Timothy R Larsen1, Alehegn Gelaye1, Christopher Durando1

  • 1Department of Internal Medicine, Providence Hospital and Medical Center, Southfield, MI, U.S.A.

Abstract

Insights

A rare but serious interaction between warfarin and amoxicillin/clavulanate can cause dangerous bleeding. This case highlights the need for careful monitoring when these medications are used together, especially after dental procedures.

Area of Science:

  • Pharmacology
  • Internal Medicine
  • Hematology

Background:

  • Warfarin is a common anticoagulant for thromboembolic diseases.
  • Warfarin has numerous drug interactions requiring monitoring.
  • Antibiotics can alter warfarin's effect, increasing risks of thrombosis or bleeding.

Purpose of the Study:

  • To report an unusual clinical course of acute warfarin toxicity.
  • To highlight a rare drug interaction between warfarin and amoxicillin/clavulanate.

Main Methods:

  • A 53-year-old male with protein C deficiency and thrombosis history developed a dental abscess.
  • Patient was treated with amoxicillin/clavulanate and underwent tooth extraction.
  • Significant bleeding occurred post-extraction, with INR of 20.4.

Main Results:

  • The patient experienced severe bleeding after tooth extraction while on amoxicillin/clavulanate and warfarin.
  • International Normalized Ratio (INR) was critically elevated at 20.4.
  • Treatment with fresh frozen plasma and vitamin K resolved the bleeding.

Conclusions:

  • Concomitant use of amoxicillin/clavulanate and warfarin can lead to prolonged prothrombin time and life-threatening bleeding.
  • Prompt recognition and intervention are crucial for managing this rare but severe drug interaction.
  • This interaction underscores the importance of vigilant patient monitoring.

Related Concept Videos

Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
423
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s...
141
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
220